Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
187.88
+2.04 (1.10%)
Aug 24, 2026, 2:46 PM EDT - Market open
Nutex Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 846.72 | 875.26 | 479.95 | 247.65 | 219.29 | 331.53 | |
Revenue Growth | 6.88% | 82.36% | 93.80% | 12.93% | -33.85% | 20.98% |
Cost of Revenue | 385.19 | 403.95 | 259.12 | 189.78 | 190.74 | 144.59 |
Gross Profit | 461.53 | 471.31 | 220.83 | 57.87 | 28.55 | 186.94 |
Selling, General & Admin | 66.68 | 58.15 | 47.52 | 38.73 | 19.81 | 5.46 |
Operating Expenses | -19.74 | 78.69 | 83.05 | 59.16 | 33.13 | 13.12 |
Operating Income | 481.27 | 392.63 | 137.78 | -1.29 | -4.58 | 173.82 |
Interest Expense | -19.78 | -22.23 | -19.93 | -16.32 | -12.49 | -6.2 |
Other Non Operating Income (Expenses) | -1.01 | -8.62 | -0.94 | -0.4 | -0.56 | -0.12 |
EBT Excluding Unusual Items | 460.48 | 361.78 | 116.91 | -18.01 | -17.63 | 167.5 |
Merger & Restructuring Charges | - | - | - | -29.34 | -3.89 | -3.55 |
Impairment of Goodwill | - | - | -3.2 | -1.14 | -398.14 | - |
Asset Writedown | - | - | -3.89 | - | - | - |
Other Unusual Items | -117 | -117 | - | - | - | 5.55 |
Pretax Income | 343.48 | 244.78 | 109.83 | -48.49 | -419.65 | 169.49 |
Income Tax Expense | 70.99 | 64.42 | 15.02 | -5.07 | 13.09 | 0.97 |
Earnings From Continuing Operations | 272.49 | 180.36 | 94.81 | -43.42 | -432.74 | 168.53 |
Minority Interest in Earnings | -92.57 | -109.57 | -42.71 | -2.36 | 7.96 | -35.93 |
Net Income | 179.92 | 70.79 | 52.1 | -45.79 | -424.78 | 132.59 |
Net Income to Common | 179.92 | 70.79 | 52.1 | -45.79 | -424.78 | 132.59 |
Net Income Growth | 219.32% | 35.88% | - | - | - | 25.12% |
Shares Outstanding (Basic) | 7 | 6 | 5 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 7 | 7 | 5 | 4 | 4 | 4 |
Shares Change | 14.84% | 23.03% | 24.57% | 4.15% | 7.10% | - |
EPS (Basic) | 26.35 | 11.13 | 10.23 | -10.39 | -100.36 | 33.55 |
EPS (Diluted) | 25.24 | 10.48 | 9.69 | -10.39 | -100.36 | 33.00 |
EPS Growth | 172.78% | 8.13% | - | - | - | 23.07% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 271.85 | 241.29 | 20.85 | -8.24 | 35.97 | 136.51 |
Free Cash Flow Per Share | 38.12 | 35.71 | 3.80 | -1.87 | 8.50 | 34.54 |
Gross Margin | 54.51% | 53.85% | 46.01% | 23.37% | 13.02% | 56.39% |
Operating Margin | 56.84% | 44.86% | 28.71% | -0.52% | -2.09% | 52.43% |
Profit Margin | 21.25% | 8.09% | 10.85% | -18.49% | -193.70% | 39.99% |
Free Cash Flow Margin | 32.11% | 27.57% | 4.34% | -3.33% | 16.41% | 41.17% |
EBITDA | 502.27 | 413.16 | 156.76 | 16.3 | 8.55 | 181.48 |
EBITDA Margin | 59.32% | 47.20% | 32.66% | 6.58% | 3.90% | 54.74% |
D&A For EBITDA | 21 | 20.53 | 18.97 | 17.59 | 13.13 | 7.66 |
EBIT | 481.27 | 392.63 | 137.78 | -1.29 | -4.58 | 173.82 |
EBIT Margin | 56.84% | 44.86% | 28.71% | -0.52% | -2.09% | 52.43% |
Effective Tax Rate | 20.67% | 26.32% | 13.68% | - | - | 0.57% |
Revenue as Reported | 846.72 | 875.26 | 479.95 | 247.65 | 219.29 | 331.53 |